InspireMD stent shows positive trial results

05/5/2008 | FDAnews

A multicenter trial in Germany found no thrombosis and low incidence of major adverse cardiac events in high-risk patients with complex lesions who received InspireMD Ltd.'s MGuard coronary stent. The device has been approved by European regulators for coronary artery disease treatment.

View Full Article in:

FDAnews

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Director of Governmental Programs
Bluegrass Family Health
Lexington, KY